The 2011 PAH debate: what is the biggest challenge we face to optimise patient outcome?

Evening Symposium
Chairs: A. Boonstra (Amsterdam, The Netherlands)

Chairman’s welcome and introduction A. Boonstra (Amsterdam, The Netherlands)
The biggest challenge we face in PAH today is … To diagnose patients sooner C.D. Vizza (Rome, Italy)
The biggest challenge we face in PAH today is … To recognise deterioration sooner M. Delcroix (Leuven, Belgium)
The biggest challenge we face in PAH today is … To treat more aggressively I. Lang (Vienna, Austria)
Panel discussion and audience Q&A C.D. Vizza (Rome, Italy), M. Delcroix (Leuven, Belgium), I. Lang (Vienna, Austria), A. Boonstra (Amsterdam, The Netherlands)